Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2022-06-30 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2021年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021年度股东大会决议公告" which translates to "2021 Annual General Meeting Resolution Announcement." It details the date and method of the meeting, attendance, and the voting results on various proposals including the 2021 annual report, board work report, financial statements, profit distribution plan, and appointment of auditors. The document is a formal announcement of the resolutions passed at the AGM, including voting results and legal opinions confirming the validity of the meeting and votes. It does not contain the full annual report or detailed financial statements but rather the outcomes of the shareholder meeting. The document length is 4331 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-06-30 Chinese
关于公司控股股东所持公司部分股份被司法冻结的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the judicial freezing of shares held by the company's controlling shareholder. It details the number of shares frozen, the reasons for the freeze, and the impact on the company. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (1800 characters) and serves as a regulatory disclosure about a significant shareholder event affecting shareholding status. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-06-22 Chinese
2021年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled '2021年度股东大会 会议资料' which translates to '2021 Annual General Meeting (AGM) Meeting Materials'. It contains detailed agenda items for the 2021 AGM held on June 30, 2022, including the reading and discussion of the 2021 Annual Report, Board of Directors report, Supervisory Board report, financial statements, profit distribution plan, and other proposals. The document also includes instructions for shareholders attending the meeting, voting procedures, and detailed reports and proposals to be discussed at the AGM. The content is consistent with materials typically provided to shareholders for an AGM, including presentations and reports to be reviewed and voted on during the meeting. It is not the annual report itself but the meeting materials for the AGM where the annual report and other items are presented and discussed. Therefore, the correct classification is AGM Information (AGM-R).
2022-06-07 Chinese
关于召开2021年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2021 Annual General Meeting (AGM) of the company 启迪药业集团股份公司. It includes information about the meeting date, voting procedures, proposals to be voted on (including the 2021 annual report, board reports, financial statements, profit distribution plan, and other corporate matters), and instructions for shareholders on how to participate and vote either in person or via internet voting. The document does not contain the actual annual report or financial statements but rather serves as a formal announcement and invitation to the AGM with related procedural details. The presence of agenda items such as the annual report and financial statements indicates it is related to the AGM, but since the document itself is the notice of the meeting and voting instructions, it fits the category of AGM Information (AGM-R). The document length (4822 characters) and content confirm it is not a brief announcement or a report publication announcement but a full AGM notice.
2022-06-07 Chinese
关于公司向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 启迪药业集团股份公司 regarding the company's plan to apply for a comprehensive credit facility from banks, including details about the credit limit and intended use. It mentions the board meeting approving the proposal and that the matter will be submitted to the shareholders' meeting for approval. The document is short (624 characters) and is an announcement of a financing activity, not a detailed financial report or results. It does not contain financial statements or detailed analysis, but rather an update on capital/financing activities. Therefore, it fits best under Capital/Financing Update (CAP).
2022-06-07 Chinese
第九届董事会临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a temporary board meeting of the company. It includes details about the meeting date, voting results, and references to other announcements for more information. The content focuses on board decisions such as applying for a credit facility and scheduling the annual shareholders meeting. There are no financial statements, audit information, or detailed reports included. The document is not a full report but an announcement of board meeting resolutions. This fits the category of Board/Management Information (MANG). The document length is short and it does not contain financial data or detailed presentations, so it is not an Annual Report or Interim Report. Therefore, the classification is MANG with high confidence.
2022-06-07 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.